Title of article
Daily Consumption of Caper Fruit Along With Atorvastatin Has Synergistic Effects in Hyperlipidemic Patients: Randomized Clinical Trial
Author/Authors
Sardari, Saeed Department of Iranian Traditional Medicine - Shahed University , Fallahi, Faramarz Department of Cardiology Mostafa Khomeini Hospital - Shahed University , Emadi, Fatemeh Department of Iranian Traditional Medicine - Shahed University , Davati, Ali Department of Iranian Traditional Medicine - Shahed University , Khavasi, Narjes Department of Iranian Traditional Medicine - Shahed University , Gholamifesharaki, Mohammad Department of Persian Medicine - School of Medicine - Zanjan University of Medical Sciences , Esmaeili, Saeid Department of Biostatistics - Tarbiat Modares University
Pages
7
From page
1
To page
7
Abstract
Background: Dyslipidemia leads to micro- and macro-vascular complications. Atorvastatin is
the main therapeutic drug used for dyslipidemia, but it causes side effects such as new type 2
diabetes mellitus onset and elevation of liver enzymes. Herbs may be useful in reducing atorvastatin doses. Caper fruit, an herbal drug in Persian Medicine, has hypolipidemic effects. Hence,
the effect of atorvastatin therapy with and without daily caper fruit pickle (CFP) consumption
was assessed on hyperlipidemia. Materials and Methods: In this single-blinded, randomized,
controlled trial, 60 hyperlipidemic patients were allocated in two groups and treated with 10
mg atorvastatin plus 40-50 g CFP (A10+CFP) or atorvastatin alone (A10) for eight weeks.
Biochemical parameters were measured at baseline, 4, and eight weeks of the intervention.
One-way repeated measure ANOVA and mixed ANOVA were used to measure the effect of
the two treatments and the interaction between the type of treatment and time on lipid profile.
Results: Serum total cholesterol and low-density lipoprotein cholesterol (LDL-C) were significantly decreased in the A10+CFP group compared with the A10 group (P<0.001 and P<0.001,
respectively) from baseline up to the week 8. At week 4, mean changes of LDL-C was significantly higher in the A10+CFP compared with the A10 (P=0.01). Adjusting for the baseline
variables, the mean difference of alanine aminotransferase (P<0.01) and triglyceride (P=0.003)
were significantly higher in the A10+CFP group at the end. Conclusion: This study reports that
the intake of CFP along with atorvastatin daily may have synergistic effects which improve
the lipid profile in hyperlipidemic patients
Keywords
Caper , Atorvastatin , Lipid Profile
Journal title
Galen Medical Journal (GMJ)
Serial Year
2019
Record number
2500598
Link To Document